AGA has released new guidelines providing five recommendations for the use of endoscopic eradication therapy (EET) in patients with Barrett's esophagus (BE) and related neoplasia.
For patients with low-grade dysplasia, it may be appropriate to either remove or monitor the cells. This is a decision doctors and patients should make together after discussing the risks and benefits of treatment.